Cipla Limited's wholly-owned subsidiary, Cipla (EU) Limited, UK, has incorporated a new wholly-owned subsidiary named ‘CiplaRna GmbH’ in Germany, effective 28th May 2025.
CiplaRna GmbH was incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.
CiplaRna is considered a related party, but none of the promoters/promoter groups/group companies have any interest in it.
Cipla (EU) Limited has subscribed to 25,000 shares of EUR 1 each at par, acquiring 100% shareholding.